Buchillon, Switzerland

Mermod Nicolas


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mermod Nicolas: Innovator in Gene Transfer Technology

Introduction

Mermod Nicolas is a notable inventor based in Buchillon, Switzerland. He has made significant contributions to the field of genetic engineering, particularly in the area of gene transfer and expression in mammalian cells. His innovative work has the potential to enhance protein production in eukaryotic cells, which is crucial for various biotechnological applications.

Latest Patents

Mermod Nicolas holds a patent titled "High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of MAR sequences." This invention relates to purified and isolated DNA sequences that have protein production increasing activity. Specifically, it focuses on the use of matrix attachment regions (MARs) to enhance protein production activity in eukaryotic cells. The patent also discloses a method for identifying these active regions, particularly MAR nucleotide sequences, and introduces a new multiple transfection method utilizing these characterized active MAR sequences.

Career Highlights

Mermod Nicolas is associated with Selexis S.A., a company that specializes in the development of mammalian cell lines for the production of biopharmaceuticals. His work at Selexis has been instrumental in advancing the capabilities of gene transfer technologies, making significant strides in the efficiency of protein production.

Collaborations

Mermod Nicolas has collaborated with esteemed colleagues such as Pierre Alain Girod and Philipp Bucher. These collaborations have fostered a productive environment for innovation and research in the field of genetic engineering.

Conclusion

Mermod Nicolas is a pioneering inventor whose work in gene transfer technology has the potential to revolutionize protein production in mammalian cells. His contributions are vital for the advancement of biotechnological applications and the development of new therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…